Search

Search results

4994 results found

Clobetasol propionate emulsion formulation foam 0.05%: review of phase II open-label and phase III randomized controlled trials in steroid-responsive dermatoses in adults and adolescents.

Kimball, Alexa Boer, Michael H Gold, Beth Zib, Mark W Davis, and Clobetasol Propionate Emulsion Formulation Foam Phase Clinical Study Group III. 2008. “Clobetasol Propionate Emulsion Formulation Foam 0.05%: Review of Phase II Open-Label and Phase III Randomized Controlled Trials in Steroid-Responsive Dermatoses in Adults and Adolescents.”. Journal of the American Academy of Dermatology 59 (3): 448-54, 454.e1.

Adalimumab alleviates skin pain in patients with moderate-to-severe hidradenitis suppurativa: Secondary efficacy results from the PIONEER I and PIONEER II randomized controlled trials.

Kimball, Alexandra B, Murali Sundaram, Alan L Shields, Stacie Hudgens, Martin Okun, Catherine Foley, and Arijit Ganguli. 2018. “Adalimumab Alleviates Skin Pain in Patients With Moderate-to-Severe Hidradenitis Suppurativa: Secondary Efficacy Results from the PIONEER I and PIONEER II Randomized Controlled Trials.”. Journal of the American Academy of Dermatology 79 (6): 1141-43.